Valuation: NetraMark Holdings Inc.

Market Cap 6.15Cr 4.45Cr 3.82Cr 3.57Cr 3.27Cr 425.42Cr 6.25Cr 42Cr 16Cr 213.36Cr 17Cr 16Cr 705.44Cr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 6.15Cr 4.45Cr 3.82Cr 3.57Cr 3.27Cr 425.42Cr 6.25Cr 42Cr 16Cr 213.36Cr 17Cr 16Cr 705.44Cr EV / Sales 2026 *
153x
EV / Sales 2027 * -
Free-Float
91.14%
Yield 2026 *
-
Yield 2027 * -
1 week-2.99%
Current month-18.75%
1 month-18.75%
3 months-26.14%
6 months-39.25%
Current year-40.91%
1 week 0.62
Extreme 0.62
0.75
1 month 0.62
Extreme 0.62
0.85
Current year 0.59
Extreme 0.59
1.28
1 year 0.59
Extreme 0.59
1.8
3 years 0.16
Extreme 0.155
1.8
5 years 0.15
Extreme 0.15
1.97
10 years 0.15
Extreme 0.15
3.17
Manager TitleAgeSince
Chief Executive Officer - 17/02/2022
President - 04/07/2022
Director of Finance/CFO 57 18/07/2022
Director TitleAgeSince
Chairman 40 09/06/2025
Director/Board Member - -
Director/Board Member - 16/06/2022
Date Insider Type Main position Quantity % Market Cap.
13/04/26 Tax

Chairperson

4,34,178 0.4686%
19/02/26 Option

Executive/Senior Manager

1,16,250 0.1354%
19/02/26 Other

Executive/Senior Manager

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-2.99%-61.76%+165.31% 4.43Cr
+0.61%-1.78%-5.12%+50.26% 3,57600Cr
+2.02%+2.40%+11.03%+1,107.93% 41TCr
+0.03%-2.19%-8.89%+40.47% 8.72TCr
-4.79%-3.31%+80.59%+146.00% 8.83TCr
-0.35%-2.40%-34.33%-7.80% 7.74TCr
+2.80%-6.95%-33.50%+208.28% 7.12TCr
-2.23%-2.27%+4.00%+70.17% 4.53TCr
+6.90%+11.66%+4.29%-5.87% 4.13TCr
-4.45%-10.57%+113.45%+264.20% 3.56TCr
Average -0.06%-3.71%+6.98%+203.89% 44.35TCr
Weighted average by Cap. +0.62%-4.07%-1.82%+153.21%

Financials

2026 *2027 *
Net sales 4L 3L 2L 2L 2L 2.77Cr 4L 27.42L 10.74L 1.39Cr 10.89L 10.66L 4.6Cr -
Net income - -
Net Debt - -
Logo NetraMark Holdings Inc.
NetraMark Holdings Inc. is a Canada-based company, which is focused on the development of Generative Artificial Intelligence (Gen AI)/Machine Learning (ML) solutions targeted at the pharmaceutical industry. The Company’s product offering uses a novel topology-based algorithm that has the ability to parse patient data sets into subsets of people that are strongly related according to several variables simultaneously. This allows the Company to use a variety of ML methods, depending on the character and size of the data, to transform the data into powerfully intelligent data that activates traditional AI/ML methods. The result is that it can work with smaller datasets and accurately segment diseases into different types, as well as accurately classify patients for sensitivity to drugs and/or efficacy of treatment. The typical molecular data used is RNASeq, microarray, single nucleotide polymorphism (SNP) and methylation.
Employees
-
Date Price Change Volume
20/26/20 CA$0.6500 0.00% 32,652
18/26/18 CA$0.6500 -5.80% 41,402
17/26/17 CA$0.6900 +1.47% 1,15,000
14/26/14 CA$0.6800 +3.03% 11,638
13/26/13 CA$0.6600 -1.49% 26,500

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AIAI Stock